IGF2BP1 and ovarian cancer: ROS and Fe2+ detection showed that in CACNA1G-AS1-overexpressing ovarian cancer cells, the ROS and Fe2+ contents significantly decreased, while these changes could be reversed by IGF2BP1 and FTH1 inhibition.